| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 53.748 | 49.667 | 56.940 | 68.588 | 81.597 | 91.825 | 87.166 |
| Total Income - EUR | - | - | - | 53.748 | 49.667 | 58.119 | 68.590 | 81.599 | 91.830 | 87.167 |
| Total Expenses - EUR | - | - | - | 38.370 | 43.346 | 32.534 | 43.321 | 55.509 | 56.677 | 64.104 |
| Gross Profit/Loss - EUR | - | - | - | 15.377 | 6.321 | 25.585 | 25.269 | 26.090 | 35.154 | 23.064 |
| Net Profit/Loss - EUR | - | - | - | 14.840 | 5.824 | 25.206 | 24.630 | 25.290 | 34.346 | 20.501 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dermastayle Medclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.081 | 1.206 | 1.612 | 30.347 | 25.538 | 17.864 | 17.587 |
| Current Assets | - | - | - | 15.264 | 20.650 | 44.570 | 26.604 | 31.577 | 39.768 | 14.502 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 4.077 | 0 | 1.187 | 32 | 17.249 | 3.958 | 0 |
| Cash | - | - | - | 11.188 | 20.650 | 43.383 | 26.573 | 14.328 | 35.811 | 14.502 |
| Shareholders Funds | - | - | - | 14.883 | 20.419 | 45.237 | 24.678 | 25.070 | 42.590 | 20.549 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.463 | 1.437 | 945 | 32.273 | 32.044 | 15.042 | 11.540 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermastayle Medclinic Srl